<DOC>
	<DOCNO>NCT00042718</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness four oral antibiotic treatment regimens bacterial infection patient chronic bronchitis . The study goal demonstrate 1 ) levofloxacin 750 mg daily three day bad azithromycin 250 mg twice day one day 250 mg day four day , 2 ) levofloxacin 750 mg daily five day bad amoxicillin/ clavulanate ( 875/125 mg ) twice daily 10 day .</brief_summary>
	<brief_title>A Study Effectiveness Safety High Dose , Short-course Levofloxacin Treatment Acute Bacterial Exacerbation ( Worsening ) Chronic Bronchitis .</brief_title>
	<detailed_description>This randomize , double-blind , multicenter treatment study evaluate efficacy safety high-dose , short-course oral levofloxacin treatment versus treatment oral antibiotic acute bacterial exacerbation chronic bronchitis ( ABECB ) . This study evaluate use high-dose ( 750 milligram ) short-course ( 3 5 day ) levofloxacin compare conventional dos schedule effective antibiotic control acute bacterial infection patient chronic bronchitis , The study divide 700 patient two group -- one group le severe ( uncomplicated ) chronic bronchitis , one severe ( complicate ) chronic bronchitis . Patients uncomplicated disease receive levofloxacin 750 mg daily 3 day azithromycin 250 mg twice day 1 day 250 mg day 4 day . Patients complicate disease receive levofloxacin 750 mg daily 5 day amoxicillin/ clavulanate ( 875/125 mg ) twice daily 10 day . All patient take study medication orally . Effectiveness measure compare patient 's sign symptom present Test-of-Cure Visits ( study day 13 - 22 ) observe Study Entry Visit . Safety evaluate throughout study basis occurrence severity unexpected undesirable event well laboratory test physical examination . The hypothesis study short course ( 3 day ) 750 mg levofloxacin least effective well tolerate azithromycin 5 day uncomplicated ABECB , 750 mg levofloxacin 5 day least effective well tolerate amoxicillin/ clavulanate 10 day cure complicate ABECB case . Uncomplicated ABECB : Oral dos levofloxacin 750 mg daily 3 day , azithromycin 250 mg twice daily day 1 , 250 mg daily day 2 - 5 . Complicated ABECB : Oral dos levofloxacin 750 mg daily 5 day , amoxicillin/clavulante 875/125 mg daily 10 day .</detailed_description>
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<mesh_term>Bronchitis , Chronic</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>History chronic bronchitis Diagnosis Type1 Type2 acute bacterial exacerbation ( worsen ) chronic bronchitis ( ABECB ) least presence increase sputum production increase sputum purulence evidence inflammatory cell If female , must postmenopausal , surgically sterile , practice effective method birth control Diagnosis bronchial asthma Allergy serious adverse reaction study medication antibiotic Failed treatment pneumonia acute bacterial exacerbation ( worsen ) chronic bronchitis ABECB three month prior enrollment study study medication antibiotic Can tolerate medication take mouth</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Chronic Bronchitis</keyword>
	<keyword>Acute Bacterial Exacerbation Chronic Bronchitis</keyword>
</DOC>